725 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Bought by Aigen Investment Management LP

Key Points

• Aigen Investment Management LP has acquired a new stake in Intuitive Surgical, Inc., purchasing 725 shares valued at approximately $359,000 during the 1st quarter of 2023.
• Shares of Intuitive Surgical recently opened at $482.35, with a market capitalization of $172.91 billion and a price-to-earnings ratio of 67.27.
• Analysts maintain a consensus average rating of "Moderate Buy" for Intuitive Surgical, with a target price set at approximately $595.95.

Aigen Investment Management LP bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 725 shares of the medical equipment provider's stock, valued at approximately $359,000.

A number of other hedge funds also recently bought and sold shares of the stock. AlphaCore Capital LLC grew its position in shares of Intuitive Surgical by 4.2% in the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock valued at $235,000 after purchasing an additional 18 shares during the last quarter. Second Line Capital LLC raised its stake in Intuitive Surgical by 3.4% during the fourth quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock worth $302,000 after purchasing an additional 19 shares during the period. Colonial Trust Co SC raised its stake in Intuitive Surgical by 8.8% during the fourth quarter. Colonial Trust Co SC now owns 246 shares of the medical equipment provider's stock worth $128,000 after purchasing an additional 20 shares during the period. Crown Wealth Group LLC raised its stake in shares of Intuitive Surgical by 4.8% in the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock valued at $218,000 after acquiring an additional 20 shares during the period. Finally, FSM Wealth Advisors LLC raised its stake in shares of Intuitive Surgical by 3.8% in the 1st quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider's stock valued at $270,000 after acquiring an additional 20 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Trading Up 0.7%

Shares of NASDAQ:ISRG traded up $3.18 on Friday, hitting $480.26. The company had a trading volume of 1,436,064 shares, compared to its average volume of 2,192,612. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The stock has a market cap of $172.16 billion, a price-to-earnings ratio of 66.98, a P/E/G ratio of 5.00 and a beta of 1.59. The stock has a 50 day moving average price of $508.75 and a 200 day moving average price of $525.48.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business's revenue for the quarter was up 21.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.78 earnings per share. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have commented on ISRG shares. Wall Street Zen upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Saturday, July 26th. Robert W. Baird dropped their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Truist Financial boosted their price objective on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. Evercore ISI boosted their target price on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research note on Tuesday, July 8th. Finally, UBS Group boosted their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a research note on Wednesday, July 23rd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $595.95.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Gary S. Guthart sold 2,800 shares of Intuitive Surgical stock in a transaction dated Monday, July 28th. The shares were sold at an average price of $495.24, for a total value of $1,386,672.00. Following the transaction, the insider directly owned 18,520 shares of the company's stock, valued at $9,171,844.80. The trade was a 13.13% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,839 shares of company stock valued at $7,896,972 in the last quarter. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.